Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

ELEKTA RECEIVES U.S. REGULATORY APPROVAL FOR TREATMENT PLANNING ON LEKSELL GAMMA KNIFE® PERFEXION™

PRESS RELEASE Stockholm, Sweden, July 13, 2006 On July 5, the U.S. Federal Drug Administration (FDA) announced a 510(k) pre-market clearance for Leksell GammaPlan® PFX™, the treatment planning system developed for Leksell Gamma Knife® Perfexion™.By the ongoing market introduction of Leksell Gamma Knife Perfexion, Elekta expands the Leksell Gamma Knife® product line with a completely new system that takes stereotactic radiosurgery to the next level and provides a radiosurgical platform for further refinement and expansion of procedures in the brain, cervical spine and head & neck regions.

Svithoid Tankers listed on the Nordic Exchange in Stockholm

Today, Svithoid Tankers AB has been listed on the O list of the Stockholm Stock Exchange. Svithoid Tankers is the forty-seventh 1) company to join the Nordic Exchange this year.Svithoid Tankers is a shipping company involving product and chemical tanker vessels. “It is gratifying to welcome a shipping company to the Nordic Exchange. Svithoid Tankers will now have increased access to the Swedish and international capital markets,” says Jenny Rosberg, President Company Services. “The listing on the Stockholm Stock Exchange will create additional prerequisites for the future growth of Svithoid

RNB completes the offer on JC and extends the acceptance period

• RNB’s offer to the shareholders and warrant holders in JC has been accepted by owners of approximately 89.4 percent of the share capital and votes in JC, calculated after full dilution with regard to outstanding warrants • RNB has decided to complete the offer and to extend the acceptance period until Au-gust 4, 2006, inclusiveRNB RETAIL AND BRANDS AB’s (publ) (Reg No 556495-4682) (“RNB”) public offer to the shareholders and warrant holders in JC AB (publ) (“JC”) has during the ordinary acceptance pe-riod, which ran to July 7, 2006, inclusive, been accepted by owners of in total 33,143,

QUARTERLY REPORT APRIL – JUNE 2006

• Karo Bio has received a milestone payment from Wyeth for the selection of a clinical development candidate in the joint LXR project for the treatment of atherosclerosis • KB5359 has been selected as candidate drug for treatment of common forms of dyslipidemia • Bioavailability study with KB2115 in new formulation successfully completed • Net sales for the six month period amounted to MSEK 15.2 (47.2) • The loss for the six month period amounted to MSEK 61.3 (42.4) • Cash flows from operating activities for the six month period amounted to MSEK -69.5 (-29.5) • Liquid assets and other short-

Sony Ericsson More than Doubles Year-on-Year Income Before Taxes

The consolidated financial summary for Sony Ericsson Mobile Communications AB (Sony Ericsson) for the second quarter ended June 30, 2006 is as follows: Q2 2005 Q1 2006 Q2 2006Number of units 11.8 13.3 15.7shipped(million)       Sales (EURO m.) 1,614           1,992             2,272Income before taxes 87 151 211(EURO m.)Net income (EURO m.) 75 109 143 Units shipped in the quarter reached 15.7 million, a 33% increase compared to

Q-Med launches a pharmaceutical in Sweden

Q-Med hereby announces that a pharmaceutical, Cosmofer® (low molecular iron dextran), has now been approved for sales in Sweden. It is estimated that sales will start towards the end of the year. Q-Med has an agreement with the Danish manufacturer Nebo/Pharmacosmos (www.pharmacosmos.com) concerning sales rights for the preparation on the Swedish market. Cosmofer is given through an infusion in a vein or as an injection in a muscle. What is unique for Cosmofer is that the patient’s total need can be given in a single dose. The product is used for the treatment of serious iron deficiency

The EU’s new generation of environmental policy must find global solutions to global problems

An unofficial meeting of environment ministers on 14-16 July, during Finland’s EU Presidency, will discuss a new generation of environmental ideas. The Finnish Forest Industries Federation thinks Finland should do its utmost to foster global solutions to global problems. The European Union must bear its share of responsibility for taking care of and improving the state of the planet’s environment using measures it can implement without jeopardising the prosperity of Europe. A new generation of environmental policy should also take into account the significance of renewable natural resources

Ministry of the Environment Press Release: Kvarken Archipelago becomes Finland’s first site on UNESCO’s world natural heritage list

At its meeting in Lithuania on 12 July 2006, UNESCO’s World Heritage Committee accepted the nomination to include the Kvarken Archipelago on the World Heritage List. The decision will be confirmed on Sunday 16 July 2006. The Kvarken Archipelago is Finland’s first Natural Heritage Site and is in addition to the six Cultural World Heritage Sites in Finland. "I believe that the highest possible status accorded to the Kvarken will further add to the area’s importance, not just locally among the people and organisations living and working in the region, but also nationally. If the experience of

Incentive plan launched

The annual general meeting of Acando held on 27 April 2006 decided on implementing an incentive plan for the employees, based on warrants and options. During the period May – June, the incentive plan has been launched and 297 employees of Acando have applied for warrants and 54 directors and other key personnel have acquired shares and subscribed for options. According to the preliminary calculations, these 297 employees have subscribed for 1 559 055 out of the 2.5 million warrants. The 54 persons have acquired totally 405 000 out of the 420 000 shares that Acando has repurchased from the

Bure to divest holding in Carl Bro

Bure has today signed an agreement to sell its shares in the engineering group Carl Bro to Dutch engineering group Grontmij. Carl Bro and Grontmij will join forces to form a company with some 6,200 employees and significant operations in The Netherlands, Denmark, Sweden, the UK/Ireland, Belgium and Germany, as well as extensive international activities. The sale is conditional on approval from the relevant competition authorities and Grontmij’s shareholders.In return for its 66.1 per cent holding, Bure will receive total purchase consideration of approximately SEK 1,020 million. Of this

Invitation to press and analysts briefing

Press representatives and analysts are invited to a briefing held by OMX on Wednesday, July 19, 2006, in conjunction with the presentation of OMX’s interim report for January-June 2006. The report is scheduled for publication at 8:00 a.m. on the same date. Time of briefing: 10:00 a.m. Venue: OMX’s premises at Tullvaktsvägen 15, Stockholm The report will be presented by President and CEO Magnus Böcker and CFO Kristina Schauman. Coffee will be served following the presentation. The press and analysts briefing will be broadcast live at www.omxgroup.com. The OMX website will also include

WARNER MUSIC SWEDEN TO ACQUIRE LEADING SWEDISH INDEPENDENT LABEL, MARIANN

12th July 2006 - London, UK: Warner Music Sweden (WMS) and Warner Chappell Music Scandinavia (WCMS) today announced the acquisition of Mariann, a Swedish recording and publishing company with rights to over 8,500 master tracks and 1,150 copyrights. Mariann is the home of Sweden’s premier catalogue of schlager and dansband music, dating from the 1970s onwards. The company holds the rights to many of the artists entering the ‘Melodifestivalen’, the competition to find Sweden’s Eurovision Song Contest entry and is also credited with over 300 hits on the Svensktoppen (the longest running

Meet Saab CEO Åke Svensson at Farnborough Air Show

Saab is delighted to invite you to a Press Conference with Saab CEO Åke Svensson on Tuesday 18 July at 10.00 hrs.Mr. Åke Svensson main focus will be: • Saab’s future development • The Gripen market opportunities • The expansion through the acquisition of Ericsson Microwave Systems • Development of Airborne Surveillance Systems • The expansion in South Africa During the press Conference, Mr. Svensson will be joined by Mr. Johan Lehander the Managing Director for Gripen International. The Press Conferences will be held at the Saab Chalet C24-26 in row C. Breakfast will be served from 09.30

Invitation to press and telephone conferences on 19 July 2006

The interim report of Fortum Corporation for January-June 2006 will be published on 19 July 2006, at about 9 a.m. Finnish time (GMT +2). A press conference (in Finnish) will be arranged at 11.00 a.m. Finnish time in the auditorium of our head office, Keilaniementie 1, Espoo. The press conference will be webcasted and available on our website. A buffet lunch will be served after the press conference. You can also participate in an international teleconference for analysts and investors at 4.00 p.m. Finnish time on the same day by dialing +44 (0) 20 7365 8426 (if calling from Europe) or +1

Mandatory notification of trade

(Lysaker, Norway, 12 July 2006) Today, Bernt-Olav Røttingsnes, who has been appointed CFO in Navamedic from August, has acquired a total of 6,000 shares in Navamedic ASA.The 6,000 shares were purchased at an average price of NOK 13,27 per share. Mr. Bernt-Olav Røttingsnes has a new holding in Navamedic after the purchase of 6,000 shares. For further information, please contact: Jon W. Ringvold, CFO/IRO E-mail: jon.ringvold@navamedic.com Office: +47 67 11 25 44 Mobile: +47 99 15 85 34 About Navamedic ASA: Navamedic is a Norwegian speciality pharmaceutical company

NCC to construct golf resort in Denmark for SEK 214 MSEK

Lübker Golf A/S and Rekbül ApS have entered into a partnering agreement with NCC Construction Denmark regarding the construction of the Lübker Golf Resort at Djursland, Denmark. From NCC’s viewpoint, the assignment is worth approximately SEK 214 million, with an opportunity for additional orders.NCC will construct the clubhouse, vacation accommodation, condominiums, an adventure swimming complex, a wellness center and several other buildings for the new Lübker Golf Resort at Djursland. The order encompasses a total of 15,000 square meters of floor space and the agreement also provides

Large contract for Veidekke at Majorstua in Oslo

Veidekke Entreprenør AS has signed a construction contract for  the Nye Majorproject at Sørkedalsveien 7-13 at Majorstua in Oslo. The contract price isapproximately NOK 350 million excl. VAT and the companies behind the projectare Fram Eiendom A/S and AS Naturbetong. The contract includes the building of 300 new flats and 5,000 sq.m. of shopsand offices and the completion of underground parking facilities on twolevels. The ground will also be prepared for a park in the area between thebuildings. Our work starts at the beginning of 2007 and the building period will last

NCC to build tunnels in Norway for SEK 570 million

NCC Construction AS in Norway has signed a contract with the Norwegian Road Administration (Statens Veivesen) for construction on the Finnfast project in Rogaland. The order value is about SEK 570 million and includes an underwater tunnel between the islands of Rennesøy and Finnnøy on state highway 519 and a connecting tunnel to the island of Talgje.Civil engineering work will begin in August. Through the project, the islands of Finnnøy and Talgje in the county of Ryfylke will gain a permanent road connection to Stavanger on the mainland before the end of 2009. “This project was prioritized

Permission to implement the merger between Framfab and LB Icon granted by the Swedish Companies Registration Office. The merger is expected to be registered on July 31, 2006.

The Swedish Companies Registration Office (the “SCRO”) has granted Framfab AB (“Framfab”) and LB Icon AB (“LB Icon”) permission to implement the merger between the two companies, as resolved upon at Framfab’s Extraordinary General Meeting and LB Icon’s Annual General Meeting on May 30, 2006, respectively. As merger consideration, shareholders in LB Icon will receive one new share in Framfab for each share in LB Icon. It is the companies’ intention that the SCRO shall register the merger as well as the related issue of new Framfab shares on July 31, 2006. As a consequence of the SCRO

DNBNOR - REPURCHASE OF SHARES FROM SMALL-SCALE SHAREHOLDERS

On 22 June 2006, DnB NOR ASA presented 4 500 shareholders owning less than a round lot (100 shares) with an offer to sell their shares free of charge. At the end of the offer period, the offer had been accepted by 2,182 shareholders owning a total of 101,047 shares. Complete announcement on www.newsweb.no On 22 June 2006, DnB NOR ASA presented 4 500 shareholders owning less than a round lot (100 shares) with an offer to sell their shares free of charge. At the end of the offer period, the offer had been accepted by 2,182 shareholders owning a total of 101,047 shares. The price per share was

Eniro to publish interim report for second quarter on July 20

Eniro’s interim report for the second quarter 2006 will be published around 9.00 CET on July 20, and a telephone conference will be held at 10.00 CET on the same day. The day after, Eniro will hold a breakfast presentation in London.Telephone conference on July 20Eniro’s President and CEO Tomas Franzén will present the results for the second quarter of 2006 and answer questions. An audio recording from the telephone conference will be sent directly via Eniro’s web site under Investor Relations, Investor Service, Telephone Conferences. A presentation will also be published there about 30

Patent protection for Steen Solution™ in Australia

Vitrolife has been informed that patent protection has been granted in Australia for Steen Solution™, a solution for functional testing and reconditioning of lungs outside the body before transplantation. The product was approved for sales in Europe in January.Vitrolife’s product Steen Solution™ is part of a new method for functional testing, reconditioning and preservation of lungs outside the body. The technology enables heart-dead donors’ lungs, or lungs from brain-dead patients which are initially assessed as doubtful, to be tested outside the body for possible use. The number of organs

Catena signs lease in Drammen, Norway

Catena has signed another lease with Bilia for the company’s facility in Drammen, in Norway. Bilia, an earlier tenant in the property, is to take over a former truck plant. As a result of this transaction, Catena has no vacancies in its Norwegian property portfolio.“It is satisfying that our relationship with our most important tenant – Bilia – is continuing to develop favorably and that confidence in us has been extended,” says Peter Hallgren, President of Catena.The annual rent for the new lease amounts to SEK 866,000. The new contract does not involve any further investments for Catena.

There are no items matching the current filter
There are no more items matching the current filter
Back to top